Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The game changer: UCH-L1 and GFAP-based blood test as the first marketed in vitro diagnostic test for mild traumatic brain injury

26 Jan 2024

Abstract excerpt

INTRODUCTION: Major organ-based in vitro diagnostic (IVD) tests like ALT/AST for the liver and cardiac troponins for the heart are established, but an approved IVD blood test for the brain has been missing, highlighting a gap in medical diagnostics. AREAS COVERED: In response to this need, Abbott Diagnostics secured FDA clearance in 2021 for the i-STAT Alinity™, a point-of-care plasma blood test for mild...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to S100 Proteins and Annexins
Share to Traumatic Brain Injury and Neurovascular Disturbances
Share to Traumatic Brain Injury Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38275158
DOI: 10.1080/14737159.2024.2306876

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The game changer: UCH-L1 and GFAP-based blood test as the first marketed in vitro diagnostic test for mild traumatic brain injuryPMID 38275158Read ↗

Age-specific Reference Intervals for Serum GFAP and UCH-L1 in Children and AdolescentsSemantic proximity Read ↗

Blood-Based CNS-Injury and Inflammation Biomarkers Sampled at Acute, Subacute, and Chronic phases After Mild TBI Demonstrate Diagnostic Utility For Patients With and Without Intracranial Injuries on Acute CT and MRISemantic proximity Read ↗

Bioinformatic analysis of brain-specific miRNAs for identification of candidate traumatic brain injury blood biomarkersSemantic proximity Read ↗

Budget Impact Analysis of the Use of Specific Biomarkers GFAP and UCH-L1 in the Management of Mild Traumatic Brain Injury in SpainSemantic proximity Read ↗

GFAP Degradation in TBI: Linking Novel Modified Products to Astrocyte Pathology and Patient OutcomeSemantic proximity Read ↗

Usefulness of S100β protein in patients on antithrombotic drugs with mild traumatic brain injury: a prospective cohort study in an emergency departmentSemantic proximity Read ↗

Variation in Candidate Traumatic Brain Injury Biomarker Genes Are Associated with Gross Neurological Outcomes after Severe Traumatic Brain Injury.Semantic proximity Read ↗

A Panel of Serum MiRNA Biomarkers for the Diagnosis of Severe to Mild Traumatic Brain Injury in HumansSemantic proximity Read ↗

An Overview on the Use of miRNAs as Possible Forensic Biomarkers for the Diagnosis of Traumatic Brain InjurySemantic proximity Read ↗

Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation.Semantic proximity Read ↗

Toward a Global and Reproducible Science for Brain Imaging in Neurotrauma: The ENIGMA Adult Moderate/Severe Traumatic Brain Injury Working GroupSemantic proximity Read ↗

Trajectories of blood-based protein biomarkers in chronic traumatic brain injurySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.